UK markets closed
NIKKEI 225
38,202.37 -632.73 (-1.63%) HANG SENG
18,313.86 -165.51 (-0.90%) CRUDE OIL
78.71 +0.33 (+0.42%) GOLD FUTURES
2,321.90 -2.30 (-0.10%) DOW
38,958.93 +74.67 (+0.19%) Bitcoin GBP
50,086.36 -647.34 (-1.28%)
Alnylam Pharmaceuticals, Inc. (ALNY)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 01:35PM EDT. Market open.
| Previous close | 154.33 |
| Open | 154.08 |
| Bid | 154.46 x 100 |
| Ask | 166.78 x 200 |
| Day's range | 152.94 - 155.34 |
| 52-week range | 141.98 - 218.88 |
| Volume | |
| Avg. volume | 793,675 |
| Market cap | 19.564B |
| Beta (5Y monthly) | 0.40 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
The Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) First-Quarter Results Are Out And Analysts Have Published New Forecasts
Alnylam Pharmaceuticals, Inc. ( NASDAQ:ALNY ) just released its latest first-quarter results and things are looking...
- Insider Monkey
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript May 2, 2024 Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.52272, expectations were $-0.75. ALNY isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for […]
- Zacks
Alnylam (ALNY) Q1 Loss Narrower Than Expected, Sales Rise Y/Y
Alnylam (ALNY) reports better-than-expected first-quarter 2024 results as both earnings and revenues beat estimates, primarily driven by strong Amvuttra sales.
© 2024 Yahoo. All rights reserved.